Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Journal of Biopharmaceutical Statistics|January 8, 2014
Reliably basing conclusions on subgroups of randomized clinical trialsArmin Koch, Theodor FramkeBritish Journal of Clinical Pharmacology|August 27, 2025
Randomization in phase II trials: No exemption based on sample sizeTheodor Framke, Gernot Beutel, Arnold Ganser, et al.JMIR Mhealth and Uhealth|November 19, 2019
Quality Awareness and Its Influence on the Evaluation of App Meta-Information by Physicians: Validation StudyUrs-Vito Albrecht, Theodor Framke, Ute von JanPlos One|April 16, 2011
Effect of acute ozone induced airway inflammation on human sympathetic nerve traffic: a randomized, placebo controlled, crossover studyJens Tank, Heike Biller, Karsten Heusser, et al.BMJ Open|January 14, 2025
Which clinical trial designs and statistical approaches have been used in assessments of orphan maintenance by the European Medicines Agency between 2012 and 2022? A cross-sectional studyFabian Windfuhr, Kristina Larsson, Theodor Framke, et al.Studies in Health Technology and Informatics|June 29, 2016
Classification of Health Related ApplicationsMatthias Höhn, Ute von Jan, Theodor Framke, et al.Journal of Biopharmaceutical Statistics|February 18, 2026
Statistical methodologies for absolute and relative efficacy assessment based on single-arm trials: a scoping reviewGeorg Zimmermann, Katerina-Maria Kontouli, Stavros Nikolakopoulos, et al.Therapeutic Advances in Endocrinology and Metabolism|December 20, 2019
How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodologyMarcus May, Theodor Framke, Bernd Junker, et al.Biometrical Journal. Biometrische Zeitschrift|September 16, 2006
Confirmatory clinical trials with an adaptive designArmin KochZeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 3, 2011
[Benefits and harms - two sides of the same medal?]Armin KochPageof 11